Adaptive Biotechnologies Corporation (ADPT)
ADPT price $25.37 +0.04 +0.15%
- Ticker
- ADPT
- Price
- $25.37
- Change
- +0.04 +0.15%
- Market cap
- $4.05B
- P/E
- -62.17
- Forward P/E
- 2392.98
- Sector
- Healthcare
- Industry
- Biotechnology
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core…